DDPC: Dragon Database of Genes associated with Prostate Cancer by Maqungo, Monique et al.
DDPC: Dragon Database of Genes associated
with Prostate Cancer
Monique Maqungo
1, Mandeep Kaur
2, Samuel K. Kwofie
1, Aleksandar Radovanovic
2,
Ulf Schaefer
2, Sebastian Schmeier
2, Ekow Oppon
1, Alan Christoffels
1 and
Vladimir B. Bajic
2,*
1South African National Bioinformatics Institute, University of the Western Cape, Private Bag-X17,
Modderdam Road, Bellville, Cape Town, South Africa and
2Computational Bioscience Research Center (CBRC),
King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia
Received June 8, 2010; Revised September 4, 2010; Accepted September 11, 2010
ABSTRACT
Prostate cancer (PC) is one of the most commonly
diagnosed cancers in men. PC is relatively difficult
to diagnose due to a lack of clear early symptoms.
Extensive research of PC has led to the availability
of a large amount of data on PC. Several hundred
genes are implicated in different stages of PC,
which may help in developing diagnostic methods
or even cures. In spite of this accumulated informa-
tion, effective diagnostics and treatments remain
evasive. We have developed Dragon Database of
Genes associated with Prostate Cancer (DDPC) as
an integrated knowledgebase of genes experimen-
tally verified as implicated in PC. DDPC is distinctive
from other databases in that (i) it provides
pre-compiled biomedical text-mining information
on PC, which otherwise require tedious computa-
tional analyses, (ii) it integrates data on molecular
interactions, pathways, gene ontologies, gene
regulation at molecular level, predicted transcription
factor binding sites on promoters of PC implicated
genes and transcription factors that correspond to
these binding sites and (iii) it contains DrugBank
data on drugs associated with PC. We believe
this resource will serve as a source of useful
information for research on PC. DDPC is freely
accessible for academic and non-profit users via
http://apps.sanbi.ac.za/ddpc/ and http://cbrc
.kaust.edu.sa/ddpc/.
BACKGROUND
Prostate cancer (PC) is the second most commonly
diagnosed cancer in men and it is the sixth most
common cause of cancer death of males. PC constitutes
12% of all globally diagnosed male cancers. The rates of
incidence and mortality vary according to geographic
regions. Within the male population in developed
countries PC contributes to 19% of all reported cancer
cases and appears to be the most commonly diagnosed
male cancer. In developing countries, PC is the sixth
most common cancer in men and constitutes 5% of all
reported male cancer diagnoses (1).
PC is a heterogeneous disease manifesting itself in
varying pathological and clinical forms. It is not easy to
diagnose and treat as PC tumours may be detected only
during autopsy. Signiﬁcant advancement has been
achieved in PC diagnosis with the introduction
of prostate-speciﬁc antigen (PSA) screening (2). High-
throughput genomic technologies such as microarray
and gene sequencing have been employed to better
understand the molecular mechanisms underlying the
development and progression of PC (3). Structural
biology and rational drug design, proteomics and cell
imaging have also played a major role in understanding
receptor and drug interactions in PC (3).
Research in PC has led to the availability of vast
amounts of useful data contained in various databases.
Prostate expression database (PEDB) accessible at
http://www.pedb.org/ is a curated database that contains
tools for analysing prostate gene expression in both
disease and normal conditions (4). Another database,
prostate gene database (PGDB), accessible at http://
www.urogene.org/pgdb/ is a curated database on genes
or genomic loci related to human prostate and prostatic
diseases (5). However, neither of these databases provides
insights into the molecular context of gene functioning in
PC. Thus, we believe that information on genes
experimentally veriﬁed as involved in PC enriched with
information that provides insights into the molecular
context of their functioning in PC, such as information
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drugs and drug targets, transcription regulation, as well as
pre-compiled literature-based text-mined reports on PC,
will be a useful resource for PC researchers. To the best
of our knowledge there is no such web-based resource.
In this study, we present dragon database of genes
associated with prostate cancer (DDPC), an integrated
knowledge database that has been developed to provide
researchers with a multitude of information related to PC
and PC-related genes, with the aim to support research of
PC at a molecular level.
Description
DDPC contains information on genes that have been
experimentally veriﬁed as being involved in PC. That
information is gathered from very disparate sources.
The information is packed in a variety of ways for
inspection. For example, DDPC contains pre-compiled
text-mined data on PC, gene regulation, ontologies, infor-
mation on proteins encoded by PC-associated genes,
pathways, molecular interactions and drug-related
information. Entries in DDPC are linked to external data-
bases such as UniProt (6), SwissProt (7), KEGG pathway
database (8), TRANSFAC (9), OMIM (10) and Reactome
database (11). Drugs associated with PC have been
integrated in DDPC via DrugBank (12). This drug-related
information could aid in the search for new cancer drug
receptors and potential PC drugs.
Users can query DDPC using keywords such as gene
symbols, Entrez Gene IDs or Ensembl Gene IDs or they
can set up a batch query. Data can also be retrieved by
browsing DDPC using the ‘gene search’, ‘gene select’ and
‘transcription regulation’ catalogues. All data that was
retrieved through one of these catalogues can be down-
loaded as a spreadsheet.
We believe that DDPC, due to its rich information
content and rich information on associations of various
entities, will be a very useful and novel resource for
researchers in the ﬁeld of PC. DDPC is freely available
to academic and non-proﬁt users at http://apps.sanbi.ac
.za/ddpc/ and http://cbrc.kaust.edu.sa/ddpc/.
DDPC construction
The DDPC architecture is based on a three-layer struc-
ture, namely presentation layer, logic layer and data layer.
The logic layer comprises server side PHP and Perl
modules, whereas the presentation layer consists of an
online graphical user interface developed using DHTML
and JavaScript. DDPC is a relational database with a
MySQL data layer.
Part of the data in DDPC is manually curated to
increase the reliability and relevance of information
presented. For curation purposes, a Perl script was used
to extract 973 genes from Entrez Gene using the NCBI’s
Entrez Programming Utilities (written by Savita
Shrivastava, Canadian Bioinformatics Help Desk,
University of Alberta, Edmonton) using query strings
containing terms such as ‘prostate cancer’ and
human(orgn), ‘prostate carcinoma’, ‘prostate adenocar-
cinoma’ and other PC-related terms. We manually
extracted PC-associated genes from that list requesting
that a gene’s involvement in PC has experimental
support in literature via techniques such as western blot,
RT–PCR, immunohistochemistry, tissue microarray, etc.
In this way from 973 initially extracted genes only 704
were veriﬁed as being involved in PC. Manual curation
also provided additional information for each gene [such
as PSA levels, Gleason scores (13), clinical and pathologic-
al stages of PC], which is incorporated into DDPC to give
insights into disease progression. Data statistics for genes
incorporated in DDPC are provided at http://apps.sanbi
.ac.za/ddpc/statistics.php or http://cbrc.kaust.edu.sa/
ddpc/statistics.php in Table 1.
DDPC provides information that may help in under-
standing of the regulatory potential of PC genes and
associated regulatory networks. The database contains
information on the genes’ promoters and putative
transcription factor binding sites (TFBSs). To generate
this information, we extracted 1766 promoters each
covering a region of [1000, +200] relative to the tran-
scription start sites (TSS) of the PC genes. For this
we used a FANTOM 3 promoter set based on CAGE
libraries (14,15). Mammalian matrix models of TFBSs in
TRANSFAC Professional ver. 11.4 (9) were used to map
TFBSs to both strands of each promoter. To decrease the
incidence of false-positive TFBSs predictions, we used the
Match
TM program with a proﬁle for score thresholds that
aims to minimize false positives (16). All mammalian tran-
scription factors (TFs) known to be associated with
TRANSFAC position weight matrices were used to
obtain information on the binding of TFs to promoters
of PC genes. A total of 689 mammalian TFs with unique
IDs were extracted from TRANSFAC as associated with
our TFBS predictions. The information on predicted
TFBSs, the associated TFs and the genes they potentially
control can be mined in DDPC.
Vital DrugBank data concerning PC genes has been
incorporated into DDPC (Table 2 in http://apps.sanbi
.ac.za/ddpc/statistics.php or http://cbrc.kaust.edu.sa/
ddpc/statistics.php). These comprise ADMET descriptors,
metabolizing enzymes, drug targets, coordinate ﬁles for
proteins and small drug molecules and links to other
drug-related databases.
A pre-compiled list of text-mined information from
PubMed records has been integrated into DDPC to give
the user an overview on potential gene interactions/asso-
ciations and pathways. To generate the pre-compiled
results, the PubMed database was queried using appropri-
ate PC keywords related to each of the PC genes (e.g.
‘A26C3’ OR ‘POTE22’ AND mammal AND cancer) via
the NCBI’s Entrez programming utilities. A list of 558347
abstracts was obtained on 24 February 2009 and query
results were analysed using the dragon exploration
system (DES) from OrionCell (http://www.orioncell.org),
which was based on the ideas outlined in (17,18). DES has
been previously used in creation of several other
knowledgebases such as DDOC, DDESC and DDEC
(19–21). The text-mining dictionaries used by DES in
this process were ‘metabolites and enzymes’, ‘genes and
proteins’ and ‘chemicals with pharmacological effects’.
The text-mining results are shown as lists of tables and
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of interest with other essential biological receptors and
pathways.
In order to effectively utilize DDPC, users are
encouraged to consult the user manual available at
http://apps.sanbi.ac.za/ddpc/manual.php or http://cbrc
.kaust.edu.sa/ddpc/manual.php. It can either be viewed
in HTML format or downloaded as PDF.
UTILITY AND DISCUSSION
Although existing databases that relate to prostate or PC
such as PGDB and PEDB provide a lot of information,
they are coming short of providing means to explore the
molecular biology of PC. PGDB comprises of information
about genes speciﬁcally expressed in prostate or
documented in literature to be involved in the molecular
processes associated with normal or diseased prostate.
PGDB provides serial analysis of gene expression
(SAGE) or expressed sequence tags (ESTs) expression
data for each included gene (5). Another database,
PEDB, comprises information of ESTs from prostate
cDNA libraries and provides proteomic and experimental-
ly determined microarray data on normal and neoplastic
prostate tissues and cell lines (4).
DDPC has been developed not as a substitute for these
two repositories, but as a complement to the already avail-
able pool of information and resources. DDPC is focused
on genes shown experimentally to be involved in PC and it
contains information related to these genes and their
associations to other concepts of relevance for studies of
the molecular background of PC. Much of this infor-
mation is obtained by novel pre-compiled extensive
large-scale analyses of relevant data that otherwise
would be very difﬁcult for individual researchers to
obtain. Part of the DDPC information is manually
curated. Inclusion of genes in DDPC was veriﬁed
manually to increase the accuracy of the database.
DDPC is a fully searchable web-based knowledgebase.
Using the search and browse functionalities, data can be
retrieved via ‘gene search’, ‘gene select’, ‘transcription
regulation’, ‘batch query’ and ‘drug search’ tabs. For
example, clicking on the ‘gene search’ tab enables the
user to query the database using the categories
‘Anatomical System’, ‘Cell Line’, ‘KEGG Pathways’ and
‘GO Ontology’. By clicking on any of these categories,
users would obtain a list of genes with comprehensive
associated data. This data includes the experimental
evidence used to identify the gene’s involvement in PC,
its related proteins, eVOC ontologies (22), GO ontologies,
associated pathways, associated diseases, ortholog genes,
transcription regulations, text-mined report and
drug-related data, as well as basic information such as
gene name, gene symbol, gene ID and links to other
resources.
To support studies of the regulatory potential of PC
genes and the associated regulatory networks, DDPC
provides predicted TFBSs on the promoters of many of
the PC genes. This enables the user to understand how the
genes may interact with others in relation to their
transcription regulatory network. Genes involved in
potential pathways may give insight on the invasiveness
of cancer cells, which could lead to the understanding of
genetic changes occurring during progression (23).
These regulatory networks were beneﬁcial in identifying
biomarkers for drug discovery, prevention, therapeutic
intervention and diagnostic biomarkers for several
diseases (24–27).
DDPC also serves as a ‘one-stop shop’ database, where
information regarding a particular gene has been extracted
from other databases and enriched with information from
several additional analyses not obtainable from other
repositories. The DDPC incorporated genes were
annotated based on eVOC anatomical system category,
association with cell type, developmental stage, ex-
perimental technique, microarray platform, pathology,
taxonomy, tissue preparation and treatment.
GO ontologies have also been incorporated into DDPC
to help prevent anomalies, which sometimes arise as a
result of using multiple terms to describe molecular
processes involving genes.
Other essential features of DDPC are the integration of
metabolic pathways and text-mining results. Pathway data
for genes is mapped in the form of links to OMIM
associated diseases as well as to pathway databases that
are publicly accessible online without user registration
(KEGG and Reactome). KEGG gives information on
comprehensively analysed graphical diagrams on known
regulatory and metabolic pathways about genes.
The Reactome data model enables the integration of
mechanisms on intermediary metabolisms, regulative
pathways and signal transduction.
In the documentation, we provided instructions how
data on a gene can be obtained by browsing the ‘gene
select’ catalogue. We used androgen receptor (AR) as an
example. By clicking on the AR gene symbol, we retrieved
vital comprehensive molecular data on the AR gene in PC
development. The involvement of AR in PC was estab-
lished using immunoreactivity, immunostaining and
chromatin immunoprecipitation experiments. Some of
the functional annotations obtained from GO ontology
were prostate gland development, cell proliferation, cell
growth and other insightful concepts. It was established
that the gene is involved in the prostate cancer pathway
with KEGG entry hsa05215. We obtained further infor-
mation through OMIM (ID 313700). For example,
Newmark et al. (28) proposed that a somatic mutation
in the AR gene resulting in persistent expression could
lead to androgen-independent PC. Also, some older men
with PC have been reported to possess high titers of
autoimmune antibodies to androgen receptor (29).
Manual analysis of text is labour intensive. It should be
noted that there are more than 500000 PubMed entries on
PC genes. Therefore pre-compiled text-mining reports
generated from abstracts of PubMed entries related
to PC genes have been incorporated into DDPC.
The text-mining reports generate networks as graphical
visualizations of essential interactions between different
terms. Their representation is easy to understand.
The text-mining interactions consist of an interconnected
network of colour-coded concepts from various
D982 Nucleic AcidsResearch, 2011, Vol.39, Database issuedictionaries with links to the various abstracts containing
the concepts. To conﬁrm a relationship retrieved by
the system, the user would have to manually verify the
abstract in question and either reject or accept the
proposed association. The text-mining data also includes
a hypothesis generator, which gives information on how
different entities may associate with each other. DDPC
also contains a list of the most referenced documents
(with PubMed IDs) based on the dictionaries used and
a table of the various terms contained in the search
Figure 1. Text mining reports in DDPC: an association map between the ABC2 gene and other entity concepts in the form of an interaction network
and hypotheses.
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abstracts. For example, an entity search with the gene
ABC2 retrieves a list of colour-coded entities assigned
to their respective dictionaries with their frequency of
occurrence. This output list could be displayed in a graph-
ical or a table form. These entities co-occur with ABC2
in an abstract and this could infer a possible relationship.
Clicking on ‘draw network’ in the menu generates an inter-
action network of association maps consisting of linked
nodes of entities (Figure 1). Also, clicking on ‘generate
hypothesis’ retrieves a hypothesis involving ABC2 and
other entities. In Figure 1, we have generated hypotheses
between ABC2 and other concepts in the metabolites and
enzymes dictionary. Veriﬁcation of the hypotheses
revealed that most of the retrieved associations were
unconﬁrmed. In this case, this means that no PubMed
abstract reports the co-occurrence of the entities in
question.
Data from DrugBank has also been included in DDPC
to complement information about potential drug recep-
tors and drugs. With the incorporation of this data,
users can quickly query DDPC to obtain a list of drugs
with potential effects to PC. DDPC contains pharmaco-
logical, pharmaceutical, structural biology and chemo-
informatics data pertaining to these drugs and their
receptors. An essential feature of DDPC is the addition
of absorption, distribution, metabolism, excretion and
toxicity (ADMET) characteristics of a drug molecule,
which is critical during the early stages of drug develop-
ment (30,31). ADMET information has been provided for
each drug molecule to aid in the in silico prediction of
ADMET descriptors of analogues of these drugs.
ADMET descriptors could be used to computationally
screen large numbers of drug molecules to eliminate
those with possible undesirable ADMET characteristics.
The structures of the identiﬁed drug molecules could be
reﬁned to optimize the ADMET characteristics. One piece
of useful data that is provided is ‘percentage protein
binding’, which describes the strength of the binding
o the drug in question to plasma proteins.
This information is essential for the prediction of plasma
protein binding percentage for novel candidate drugs. The
co-ordinate ﬁles of drugs (ligands) provided in DDPC can
be downloaded to create ligand libraries for virtual
screening or docking to identify lead compounds, and
also for drug interaction and metabolism studies. DDPC
also contains links to other rich drug knowledgebases such
as RxList (http://www.rxlist.com/script/main/hp.asp)
(32), KEGG drug (http://www.genome.jp/kegg/drug/)
(8), KEGG compound (http://www.genome.jp/kegg/
compound/) (8), PubChem compound (http://www.ncbi
.nlm.nih.gov/pccompound) (33), PubChem substance
(http://www.ncbi.nlm.nih.gov/pcsubstance) (33) and
PharmGKB (http://www.pharmgkb.org/) (34).
CONCLUSION
We have developed a PC speciﬁc knowledgebase consist-
ing of information on genes reported to be implicated in
PC. This is a comprehensive database that integrates a
variety of data from other biological sources. The genes
included in DDPC are also cross-referenced to external
databases as leverage for harnessing new biological
insights. The incorporation of DrugBank drugs and drug
targets associated with PC could potentially help biologist
to relate molecular data to pharmacokinetics of drugs.
The incorporation of post-processed textual data on
PC-related MEDLINE abstracts downloaded via
PubMed could be useful for identiﬁcation of new hypoth-
esis and potential associations between disease concepts
and cellular drug targets. This database is a repository
that provides essential information for researchers
working on PC and is aimed at facilitating integration of
cross-discipline resources to accelerate answering pertin-
ent biological questions involving PC.
FUTURE DEVELOPMENTS
We plan to expand DDPC both in content and function-
ality. DDPC will be updated annually. New data on
protein–protein interactions and microarrays expression
experiments will be integrated. The gene lists will be
expanded and the present PC genes will be checked for
being up-to-date. All text mining reports will be
re-compiled with up-to-date information from PubMed
and drug data will be updated based on the current infor-
mation available in DrugBank. Incorporating additional
search and retrieval features will enhance the usability of
the web interface. Although a number of databases for
information regarding PC exist, DDPC is a unique
resource because it uniﬁes three distinctive characteristics
in a single application. It provides pre-compiled biomed-
ical text-mining information on PC. It integrates data on
molecular interactions, pathways, gene ontologies, gene
regulation at molecular level based on predicted transcrip-
tion factor binding sites on promoters of PC implicated
genes and transcription factors that correspond to these
binding sites. And it contains DrugBank data on drugs
associated with PC.
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